A pre-earnings briefing just rewrote the investment case for China's most beaten-down mega-cap.
Day: July 8, 2026
Gilead Trades at 13x. AbbVie Just Raised Guidance Again. One Is Priced Wrong.
Two biopharma giants sitting at opposite ends of the market's attention span.